Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

N/ACompletedNCT01908166

Stanford University61 enrolled

Overview

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

PRIMARY OBJECTIVES: I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results. OUTLINE: Patients undergo ultrasound elastography.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Adult Primary Liver Cancer Kidney Tumor

Interventions

ultrasound elasticity imagingPROCEDURE

Undergo ultrasound elastography

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * There are no restrictions on life expectancy * Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed * Patients of any ethnic background * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Patients should not be taking other investigational agents * No requirements due to co-morbid disease or intercurrent illness, as needed * No restrictions on allergic reactions as no imaging agent will be used * Concomitant medications for treatment of the target lesion * Pregnant or nursing patients will be excluded from the study

Locations (1)

Stanford University, School of Medicine

Stanford, California, United States

Outcomes

Primary Outcomes

Strain ratio for all lesions measured by comparing the lesion to the adjacent normal tissue

Suspicious liver and kidney lesions will be analyzed separately on a per-lesion basis. Within each population, the strain ratio of cases and controls will be compared using the Wilcoxon rank sum test, and the analysis will be illustrated using the non-parametric receiver operating characteristic (ROC).

Time frame: Up to 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.